written by reader Help Me Identify Alzheimer’s MicroCaps Winners

By bigger, February 4, 2017

I’m not sure what happened to the the original text, therefore here comes my second attempt..

I recently made two investments in tiny Alzheimer’s biotech companies: Promis Neurosciences ($PMN.TO) and Neurotrope ($NTRP $NTRPD). I’m interested in making more investment in the real estate located at the intersection of Toxic Oligomers (prions)/Tau/Synapses Regeneration. I explain the rational in a post titled Help Me Identify Alzheimer’s Microcaps Winners:


I do believe Neurotrope Phase 2b topline Readout due in April and Promis Neurosciences cohort study results due in Q2 ( http://biggercapital.squarespace.com/biggercapital-investment/2017/1/9/an-alzheimers-watershed-event-on-our-doorstep.html) could turn the Alzheimer’s world on its head.

If you know any tiny companies with great MOAs operating on that real estate, please let me know. There is a Swedish biotech company I’m following closely: Alzinova. I will be meeting the CEO at the AAIC in London this summer. If you attend, let’s meetup. If you know anything about this company please let me know. I don’t have an investment.

I usually invest directly into companies. I’m also a cheap bastard!

This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.



This site uses Akismet to reduce spam. Learn how your comment data is processed.

Inline Feedbacks
View all comments
👍 11477
👍 11477
👍 54
February 26, 2017 7:46 pm

I just received a teaser from Marc Lichtenfeld (oxford communications / lightning trader for a stock that is not public but will tie up with a company for alzheimers. ) – huge potential. no idea what is , but someone might.


a brief excerpt:
What I call the “Genius Molecule Discovery,” or GMD for short.

Here’s why it was successful…

When cells react to major stressors, they respond by shutting off a protein called “elF2 alpha.”

“The inactivation of elF2 alpha is a brake on memory consolidation,” said the lead biochemist at UCSF.

The molecule he discovered prevents cells from shutting off this protein in the brains of mice.

The scientists conducting the experiment were floored.

“It’s a beautiful little molecule,” the biochemist said, clearly moved.

But the discovery got even better…

That’s because this “Genius Molecule Discovery” was far more powerful than originally expected.

In fact, not only did GMD prevent cells from shutting off this protein, it was also virtually strengthening the cells from within.

Add a Topic
Add a Topic
Add a Topic
👍 1
👍 11

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

More Info